Literature DB >> 1148566

Mental and psychomotor speed in depression and mania.

I M Blackburn.   

Abstract

Mental and psychomotor speed scores were obtained for three affectively ill groups of bipolar depression, unipolar depression and bipolar mania, and three corresponding recovered groups. Comparisons were made among ill groups, among recovered groups, and between ill and recovered groups for each illness type. The following conclusions were drawn: 1. Though manic patients solve problems quicker than those of either depressed group, they do not differ much from normals. 2. With stress to work faster, the pateints in the two depressed groups can quicken their speed of work and bring it up to the level of the manic patients, even thought the latter also increase their speed. 3. On a psychomotor speed task, the bipolar dipressives are significantly slower than the manics and the unipolar depressives, who do not differ. 'Internal distraction' causes a slight increase in speed in all three groups, with no significant difference, but 'external distraction' speeds up the bipolar groups and slows down the unipolar depressives resulting in significant differences between the bipolars on the one hand and the unipolars on the othbr. 4. All recovered groups perform at the same level on all measures. 5. Comparison between ill and recovered groups seems to indicate that a manic illness does not affect mental ro psychomotor speed significantly when tested objectively. Unipolar depression also does not seem to affect speed functions very significantly. Thus only bipolar depressive patients seem to show true retardation, and manic patients do not show the opposite of retardation.

Entities:  

Mesh:

Year:  1975        PMID: 1148566     DOI: 10.1192/bjp.126.4.329

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  8 in total

1.  Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. III. Cross validation study on depressed patients: the psychotic motor syndrome as a possible state marker for endogenous depression.

Authors:  W Günther; R Günther; P Streck; H Römig; A Rödel
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

Review 2.  Psychomotor retardation in depression: biological underpinnings, measurement, and treatment.

Authors:  Jeylan S Buyukdura; Shawn M McClintock; Paul E Croarkin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-10-31       Impact factor: 5.067

3.  [Psychomotor disorders in psychiatric patients as a possible basis for new approaches in differential diagnosis and therapy. I. Results of initial studies in depressed and schizophrenic patients].

Authors:  W Günther; H Gruber
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983

4.  [Investigation of the suitability of efficiency tests in evaluating endogenous depression (author's transl)].

Authors:  A Gallwitz; S Lehrl
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-12-14

5.  Psychomotor retardation in elderly untreated depressed patients.

Authors:  Lieve Lia Beheydt; Didier Schrijvers; Lise Docx; Filip Bouckaert; Wouter Hulstijn; Bernard Sabbe
Journal:  Front Psychiatry       Date:  2015-01-26       Impact factor: 4.157

6.  The neurocognitive functioning in bipolar disorder: a systematic review of data.

Authors:  Eirini Tsitsipa; Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2015-12-01       Impact factor: 3.455

Review 7.  Psychomotor retardation in depression: a systematic review of diagnostic, pathophysiologic, and therapeutic implications.

Authors:  Djamila Bennabi; Pierre Vandel; Charalambos Papaxanthis; Thierry Pozzo; Emmanuel Haffen
Journal:  Biomed Res Int       Date:  2013-10-30       Impact factor: 3.411

8.  State-related differences in the level of psychomotor activity in patients with bipolar disorder - Continuous heart rate and movement monitoring.

Authors:  Maria Faurholt-Jepsen; Søren Brage; Maj Vinberg; Lars Vedel Kessing
Journal:  Psychiatry Res       Date:  2016-01-22       Impact factor: 3.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.